Quality of life and the impact of multimorbidity in patients with chronic disease: literature review
Abstract
Introduction. Diseases with high prevalence, such as high blood pressure, dementia, depression, and diabetes, can lead to multimorbidity, which is defined as the presence of more than one health condition in the same individual and is today considered a global challenge. Multimorbidity has consequences both in quality of life and in the use of healthcare services. Objective. Review of the literature regarding the identification of quality of life and the impact caused by multimorbidity in patients with chronic diseases. Materials and methods. The search included electronic databases: Ovid PubMed, Cochrane Library, and NLM Tools. Inclusion criteria included published studies on the topic of identifying the impact of multi- morbidity on quality of life in patients. More than sixty potential articles were identified, but the review included the original results of nine studies that had a direct connection to the topic of interest. Results. According to the conducted review, it was evident that mainly third-age individuals, with an average age around 60 years, presented for medical treatment for two or more diseases. In some studies, patients with low educational levels were more likely to present with multimorbidity, also showing a low quality of life as a result of the diseases. These patients exhibited difficulties even in accessing health - care services. The most frequently identified diseases were arterial hypertension, dyslipidemia, diabetes, obstructive sleep syndrome (apnea-hypopnea), anxiety, heart failure, depression, and ischemic heart dis- eases. Conclusions. Difficulties in accessing healthcare services and the coexistence of cardiometabolic and psychiatric diseases worsen the quality of life and treatment outcomes, emphasizing the need for integrat- ed and multidisciplinary approaches in managing multimorbidity in patients with chronic diseases.Keywords:
patient, quality of life, chronic disease, multimorbidity, impactDownloads
References
-
Ahamad, V., R. Mohammad, A. K. Pal, and K. R. Chouhan. 2025. “Multimorbidity and Its Association with Health-Related Quality of Life Among Older Adults in India: A Cross-sectional Analysis of LASI Wave-1.” BMC Geriatr. 25(1):740. doi:10.1186/s12877-025-06427-1.
-
Almagro, P., J. J. Soler-Cataluña, A. Huerta, D. González-Segura, B. G. Cosío, and CLAVE Study Investigators. 2024. “Impact of Comorbidities in COPD Clinical Control Criteria. The CLAVE Study.” BMC Pulm. Med. 24(1):6. doi:10.1186/s12890-023-02758-0.
-
Brijoux, T., C. Woopen, and S. Zank. 2021. “Multimorbidity in Old Age and Its Impact on Life Results.” Zeitschrift für Gerontologie und Geriatrie 54(Suppl 2):108–113. doi:10.1007/s00391-021-01920-9.
-
European Commission. 2015. “Which Priorities for a European Policy on Multimorbidity.” https://health.ec.europa.eu/events/conference-which-priorities-european-policy-multimorbidity_en.
-
Makovski, T. T., S. Schmitz, M. P. Zeegers, S. Stranges, and M. van den Akker. 2019. “Multimorbidity and Quality of Life: Systematic Literature Review and Meta-analysis.” Ageing Res. Rev. 53:100903. doi:10.1016/j.arr.2019.04.005.
-
Makovski, T. T., G. Le Coroller, P. Putrik, Y. H. Choi, M. P. Zeegers, S. Stranges, M. Ruiz Castell, L. Huiart, and M. van den Akker. 2020. “Role of Clinical, Functional and Social Factors in the Association Between Multimorbidity and Quality of Life: Findings from the Survey of Health, Ageing and Retirement in Europe (SHARE).” PLoS One 15(10):e0240024. doi:10.1371/journal.pone.0240024.
-
Page, M. J., J. E. McKenzie, P. M. Bossuyt, I. Boutron, T. C. Hoffmann, C. D. Mulrow, L. Shamseer, J. M. Tetzlaff, E. A. Akl, S. E. Brennan, R. Chou, J. Glanville, J. M. Grimshaw, A. Hróbjartsson, M. M. Lalu, T. Li, E. W. Loder, E. Mayo-Wilson, S. McDonald, L. A. McGuinness, et al. 2021. “The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews.” BMJ 372:n71. doi:10.1136/bmj.n71.
-
Wu, D., J. Xu, H. Zhang, K. Zhang, and Y. Zhu. 2025. “Multimorbidity Characteristics in Older Adults and Their Associated Factors in Complex Networks: A Cross-sectional Study.” Front. Public Health 13:1473572. doi:10.3389/fpubh.2025.1473572.
-
Van Wilder, L., B. Devleesschauwer, E. Clays, S. De Buyser, J. Van der Heyden, R. Charafeddine, P. Boeckxstaens, D. De Bacquer, S. Vandepitte, and D. De Smedt. 2022. “The Impact of Multimorbidity Patterns on Health-Related Quality of Life in the General Population: Results of the Belgian Health Interview Survey.” Qual. Life Res. 31(2):551–565. doi:10.1007/s11136-021-02951-w.
-
World Health Organization. 2016. Multimorbidity: Technical Series on Safer Primary Care. https://www.who.int/publications/i/item/9789241511650.
References
Ahamad, V., R. Mohammad, A. K. Pal, and K. R. Chouhan. 2025. “Multimorbidity and Its Association with Health-Related Quality of Life Among Older Adults in India: A Cross-sectional Analysis of LASI Wave-1.” BMC Geriatr. 25(1):740. doi:10.1186/s12877-025-06427-1.
Almagro, P., J. J. Soler-Cataluña, A. Huerta, D. González-Segura, B. G. Cosío, and CLAVE Study Investigators. 2024. “Impact of Comorbidities in COPD Clinical Control Criteria. The CLAVE Study.” BMC Pulm. Med. 24(1):6. doi:10.1186/s12890-023-02758-0.
Brijoux, T., C. Woopen, and S. Zank. 2021. “Multimorbidity in Old Age and Its Impact on Life Results.” Zeitschrift für Gerontologie und Geriatrie 54(Suppl 2):108–113. doi:10.1007/s00391-021-01920-9.
European Commission. 2015. “Which Priorities for a European Policy on Multimorbidity.” https://health.ec.europa.eu/events/conference-which-priorities-european-policy-multimorbidity_en.
Makovski, T. T., S. Schmitz, M. P. Zeegers, S. Stranges, and M. van den Akker. 2019. “Multimorbidity and Quality of Life: Systematic Literature Review and Meta-analysis.” Ageing Res. Rev. 53:100903. doi:10.1016/j.arr.2019.04.005.
Makovski, T. T., G. Le Coroller, P. Putrik, Y. H. Choi, M. P. Zeegers, S. Stranges, M. Ruiz Castell, L. Huiart, and M. van den Akker. 2020. “Role of Clinical, Functional and Social Factors in the Association Between Multimorbidity and Quality of Life: Findings from the Survey of Health, Ageing and Retirement in Europe (SHARE).” PLoS One 15(10):e0240024. doi:10.1371/journal.pone.0240024.
Page, M. J., J. E. McKenzie, P. M. Bossuyt, I. Boutron, T. C. Hoffmann, C. D. Mulrow, L. Shamseer, J. M. Tetzlaff, E. A. Akl, S. E. Brennan, R. Chou, J. Glanville, J. M. Grimshaw, A. Hróbjartsson, M. M. Lalu, T. Li, E. W. Loder, E. Mayo-Wilson, S. McDonald, L. A. McGuinness, et al. 2021. “The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews.” BMJ 372:n71. doi:10.1136/bmj.n71.
Wu, D., J. Xu, H. Zhang, K. Zhang, and Y. Zhu. 2025. “Multimorbidity Characteristics in Older Adults and Their Associated Factors in Complex Networks: A Cross-sectional Study.” Front. Public Health 13:1473572. doi:10.3389/fpubh.2025.1473572.
Van Wilder, L., B. Devleesschauwer, E. Clays, S. De Buyser, J. Van der Heyden, R. Charafeddine, P. Boeckxstaens, D. De Bacquer, S. Vandepitte, and D. De Smedt. 2022. “The Impact of Multimorbidity Patterns on Health-Related Quality of Life in the General Population: Results of the Belgian Health Interview Survey.” Qual. Life Res. 31(2):551–565. doi:10.1007/s11136-021-02951-w.
World Health Organization. 2016. Multimorbidity: Technical Series on Safer Primary Care. https://www.who.int/publications/i/item/9789241511650.



